Lee Spraggon

1.6k total citations
17 papers, 475 citations indexed

About

Lee Spraggon is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Lee Spraggon has authored 17 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Lee Spraggon's work include Renal and related cancers (7 papers), RNA Research and Splicing (5 papers) and RNA modifications and cancer (4 papers). Lee Spraggon is often cited by papers focused on Renal and related cancers (7 papers), RNA Research and Splicing (5 papers) and RNA modifications and cancer (4 papers). Lee Spraggon collaborates with scholars based in United States, United Kingdom and Belgium. Lee Spraggon's co-authors include Nicholas D. Hastie, Luca Cartegni, Joan Slight, Cathy Mendelsohn, Ekatherina Batourina, Tatiana Dudnakova, Frank Costantini, Gregg Duester, Karen Niederreither and Pascal Dollé and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Lee Spraggon

16 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lee Spraggon United States 13 397 107 89 73 48 17 475
Moonjoo Han United States 6 282 0.7× 221 2.1× 66 0.7× 42 0.6× 44 0.9× 7 483
P.M. Chou United States 9 192 0.5× 89 0.8× 23 0.3× 77 1.1× 27 0.6× 17 321
Longwang Wang China 12 263 0.7× 154 1.4× 114 1.3× 10 0.1× 26 0.5× 25 461
Diana M. Iglesias Canada 15 519 1.3× 160 1.5× 36 0.4× 235 3.2× 126 2.6× 23 665
Sachin Hajarnis United States 13 531 1.3× 36 0.3× 191 2.1× 316 4.3× 68 1.4× 15 664
Yuichi Tsujimoto Japan 9 129 0.3× 108 1.0× 45 0.5× 21 0.3× 13 0.3× 38 314
Sherie Hodges United States 9 183 0.5× 74 0.7× 78 0.9× 89 1.2× 10 0.2× 15 407
Ana Katušić Bojanac Croatia 12 307 0.8× 65 0.6× 105 1.2× 47 0.6× 96 2.0× 54 470
Alicia Malewska United States 7 218 0.5× 285 2.7× 123 1.4× 16 0.2× 11 0.2× 9 501
Yesenia Rojas United States 12 289 0.7× 98 0.9× 55 0.6× 35 0.5× 16 0.3× 14 553

Countries citing papers authored by Lee Spraggon

Since Specialization
Citations

This map shows the geographic impact of Lee Spraggon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Spraggon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Spraggon more than expected).

Fields of papers citing papers by Lee Spraggon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Spraggon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Spraggon. The network helps show where Lee Spraggon may publish in the future.

Co-authorship network of co-authors of Lee Spraggon

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Spraggon. A scholar is included among the top collaborators of Lee Spraggon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Spraggon. Lee Spraggon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kang, Hongjun, Nathan Ungerleider, Lee Spraggon, et al.. (2022). Salt-Inducible Kinase 1 is a potential therapeutic target in Desmoplastic Small Round Cell Tumor. Oncogenesis. 11(1). 18–18. 13 indexed citations
2.
Ogura, Koichi, Romel Somwar, Julija Hmeljak, et al.. (2020). Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor. Clinical Cancer Research. 27(4). 1184–1194. 24 indexed citations
3.
Spraggon, Lee, Julija Hmeljak, Heather Magnan, et al.. (2018). Abstract B12: Therapeutic potential of NTRK3 in desmoplastic small round cell tumor. Clinical Cancer Research. 24(2_Supplement). B12–B12. 1 indexed citations
4.
Spraggon, Lee, Luciano G. Martelotto, Julija Hmeljak, et al.. (2017). Generation of conditional oncogenic chromosomal translocations using CRISPR–Cas9 genomic editing and homology‐directed repair. The Journal of Pathology. 242(1). 102–112. 20 indexed citations
5.
Fan, Pang‐Dian, Giuseppe Narzisi, Anitha D. Jayaprakash, et al.. (2017). YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing.. Journal of Clinical Oncology. 35(15_suppl). 9043–9043. 4 indexed citations
6.
Rocca, Gaspare La, Scott H. Olejniczak, Álvaro González, et al.. (2015). In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA. Proceedings of the National Academy of Sciences. 112(3). 767–772. 89 indexed citations
7.
Spraggon, Lee & Luca Cartegni. (2013). Antisense modulation of RNA processing as a therapeutic approach in cancer therapy. Drug Discovery Today Therapeutic Strategies. 10(3). e139–e148. 10 indexed citations
8.
Wang, Fengwei, Lee Spraggon, J. Merregaert, et al.. (2013). Stromal Protein Ecm1 Regulates Ureteric Bud Patterning and Branching. PLoS ONE. 8(12). e84155–e84155. 31 indexed citations
9.
10.
Spraggon, Lee & Luca Cartegni. (2013). U1 snRNP-Dependent Suppression of Polyadenylation: Physiological Role and Therapeutic Opportunities in Cancer. International Journal of Cell Biology. 2013. 1–10. 24 indexed citations
11.
Castilla‐Llorente, Virginia, et al.. (2012). Mammalian GW220/TNGW1 is essential for the formation of GW/P bodies containing miRISC. The Journal of Cell Biology. 198(4). 529–544. 13 indexed citations
12.
Dudnakova, Tatiana, Lee Spraggon, Joan Slight, & Nicholas D. Hastie. (2009). Actin: a novel interaction partner of WT1 influencing its cell dynamic properties. Oncogene. 29(7). 1085–1092. 22 indexed citations
13.
Rosselot, Carolina, Lee Spraggon, Ekatherina Batourina, et al.. (2009). Non-cell-autonomous retinoid signaling is crucial for renal development. Development. 137(2). 283–292. 126 indexed citations
14.
Spraggon, Lee, et al.. (2006). hnRNP-U directly interacts with WT1 and modulates WT1 transcriptional activation. Oncogene. 26(10). 1484–1491. 31 indexed citations
15.
Miles, Colin G., Joan Slight, Lee Spraggon, et al.. (2003). Mice Lacking the 68-Amino-Acid, Mammal-Specific N-Terminal Extension of WT1 Develop Normally and Are Fertile. Molecular and Cellular Biology. 23(7). 2608–2613. 19 indexed citations
16.
Menke, Aswin, Annemieke IJpenberg, Stewart Fleming, et al.. (2003). The wt1 ‐heterozygous mouse; a model to study the development of glomerular sclerosis. The Journal of Pathology. 200(5). 667–674. 33 indexed citations
17.
Menke, Aswin, Alan R. Clarke, Kathy Williamson, et al.. (2002). Genetic interactions between the Wilms' tumor 1 gene and the p53 gene.. PubMed. 62(22). 6615–20. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moonjoo Han Breakdown of academic impact, for papers by P.M. Chou Breakdown of academic impact, for papers by Longwang Wang Breakdown of academic impact, for papers by Diana M. Iglesias Breakdown of academic impact, for papers by Sachin Hajarnis Breakdown of academic impact, for papers by Yuichi Tsujimoto Breakdown of academic impact, for papers by Sherie Hodges Breakdown of academic impact, for papers by Ana Katušić Bojanac Breakdown of academic impact, for papers by Alicia Malewska Breakdown of academic impact, for papers by Yesenia Rojas
Rankless by CCL
2026